CEL Celadon Pharmaceuticals Plc

 
TIDMCEL 
 
FRM 38.5(a) 
 
                 DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS 
                       WITH RECOGNISED INTERMEDIARY STATUS 
                      DEALING IN A CLIENT-SERVING CAPACITY 
                       (Rule 38.5(a) of the Takeover Code) 
 
 
1.   KEY INFORMATION 
 
Name of exempt principal      KBC PEEL HUNT LTD 
trader 
Company dealt in              CELSIS INTERNATIONAL PLC 
Class  of  relevant  security ORDINARY SHARES 
to  which the dealings  being 
disclosed relate (Note 1) 
Date of dealing               02 SEPTEMBER 2009 
 
 
2.   DEALINGS (Note 2) 
 
(a)  Purchases and sales 
 
Total number of          Highest price paid      Lowest price paid (Note 
securities purchased     (Note 3)                3) 
 
680                      232p                    232p 
 
 
 
Total number of          Highest price received  Lowest price received 
securities sold          (Note 3)                (Note 3) 
 
NIL                       0p                     0p 
 
 
 
(b)  Derivatives transactions (other than options) 
 
Product       Long/short       Number of securities   Price per unit 
name,         (Note 4)         (Note 5)               (Note 3) 
e.g. CFD 
 
 
 
 
(c)  Options transactions in respect of existing securities 
 
(i)  Writing, selling, purchasing or varying 
 
Product      Writing,   Number of     Exerci  Type,    Expiry  Option 
name,        selling,   securities    se      e.g.     date    money 
e.g. call    purchasing to which      price   America          paid/rece 
option       , varying  the option            n,               ived per 
             etc.       relates               Europea          unit 
                        (Note 5)              n etc.           (Note 3) 
 
 
(ii) Exercising 
 
Product name, e.g. call  Number of securities    Exercise price per unit 
option                                           (Note 3) 
 
 
 
 
3.   OTHER INFORMATION 
 
Agreements, arrangements or understandings relating to options or derivatives 
 
 
Full details of any agreement, arrangement or understanding between the 
person disclosing and any other person relating to the voting rights of 
any relevant securities under any option referred to on this form or 
relating to the voting rights or future acquisition or disposal of any 
relevant securities to which any derivative referred to on this form is 
referenced.  If none, this should be stated. 
 
 
 
 
 
 
Date of disclosure                         03 SEPTEMBER 2009 
 
Contact name                               KELLY MORGAN 
Telephone number                           020 7418 8860 
Name of offeree/offeror with which         NASTOR INVESTMENTS LIMITED 
connected                                  ("Bidco") 
Nature of connection (Note 6)              FINANCIAL ADVISOR 
 

Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Oct 2024 to Nov 2024

Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Nov 2023 to Nov 2024